Sundaram ME, Meydani SN, Vandermause M, Shay DK, Coleman LA, Vitamin E
GHK-Cu attracts a slightly different patient than most peptides
Kinetic parameters were determined using LineweaverBurk plots using KaleidaGraph 4 (Synergy Software, least squares best fit of data and varying concentrations of one substrate while maintaining the concentration of other substrates
A combination strategy can be required for vascular or blue dark circles
Combined with the NADH oxidation and cell death assays data mentioned above, these results supported that the quinone reduction and FAD hydroxylation occurred at different sites, and both activities should be related to its ferroptosis inhibition activity
BPC-157 is a research-stage compound with promising preclinical data but limited human clinical evidence